SNGX

Soligenix Inc.

Price

$0.37

return (12m)

-86.25%

p/e

-0.59

p/bv

0.91

DIVIDEND YIELD

0.00%

SNGX price

Soligenix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SNGX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.48%

3 months

-5.13%

1 year

-86.25%

2 years

-90.31%

5 years

-99.85%

10 years

-99.98%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SNGX

Valuation

P/E

-0.59

Sector -3.50

Industry -3.50

P/BV

0.91

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

1.79

Sector -214.99

Industry -214.99

EV/EBIT

1.79

Sector -47.59

Industry -47.59

P/EBITDA

-0.55

Sector -21.41

Industry -21.41

P/EBIT

-0.55

Sector -28.65

Industry -28.65

P/Total Assets

0.58

Sector 1.19

Industry 1.19

P/Net Current Assets

0.96

Sector -11.97

Industry -11.97

P/Working Capital

0.93

Sector -167.95

Industry -167.95

EPS

-0.64

Sector -1.81

Industry -1.81

BVPS

0.42

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-154.06%

Sector -56.04%

Industry -56.04%

ROA

-97.52%

Sector -60.31%

Industry -60.31%

ROIC

-1,599.24%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.77

Sector 2.89

Industry 2.89

Net Debt / EBITDA

4.68

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

4.67

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.48

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.63

Sector 0.46

Industry 0.46

Liabilities/Assets

0.37

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-3.99%

Sector -

Industry -

Fundamentals SNGX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SNGX Soligenix Inc.	$0.37	-86.25%	0.00%	-0.59	0.91	-154.06%	0.00%
JNJ Johnson & Johnson	$269.99	56.71%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.66	23.21%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.96	22.44%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.24	-26.07%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.87	87.26%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.08	10.74%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.06	48.20%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.40	-50.11%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$385.65	38.85%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.85	33.10%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.45	44.52%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.65	25.89%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$508.34	32.68%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.38	52.58%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$990.32	34.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.02	29.13%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SNGX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Soligenix

Soligenix Inc.

Average Investor10 user rating

4.0 (1 people)

United States

39 years

Founded: 1987

1994

Time since IPO - 32 years

18

Employees

Soligenix Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.06 million, with shareholders equity totaling $6.65 million.

The company employs approximately 18 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Soligenix Inc. reported $- in revenue, generating net income of $-10.24 million.

Key financial metrics include a P/E ratio of -0.59, a price-to-book (P/B) ratio of 0.91, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SNGX.

Market cap

$6.06 million

Net worth

$6.65 million

$6,646,000.00

Assets

$10.50 million

$10,499,000.00

Total Shares Outstanding

15.95 million

15,951,000

Average Daily Trading Volume

$262.93 Thousand

$262,926.00

Sector

Health Care

Industry

Biotechnology

SNGX

SNGX revenue and profits

Financial Results SNGX

DRAG THE FRAME TO SEE MORE DATA

SNGX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.65 25,89% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.38 52,58% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.96 22,44% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.87 87,26% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.08 9,00% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.66 23,21% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.65 25,89% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.38 52,58% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.96 22,44% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.87 87,26% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.08 9,00% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.66 23,21% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Soligenix (SNGX) today?

A cotação de Soligenix (SNGX) hoje está em US$ 0.37, com uma variação de -86.25% em relação ao último ano. A cotação de Soligenix (SNGX) iniciou o ano negociando na casa dos US$ 1.34 e hoje está em US$ 0.37. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Soligenix (SNGX) e dados de ações do Ibovespa e mercados internacionais.

Quando Soligenix (SNGX) paga dividendos?

Soligenix (SNGX) não distribuiu dividendos no último ano.

Is Soligenix (SNGX) a good investment?

Atualmente, Soligenix (SNGX) está cotada a US$ 0.37, com um P/L de -0.59, representando um desvio de -724% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -86.25 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -86.25%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Soligenix (SNGX) stock?

Investir em ações de Soligenix (SNGX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Soligenix (SNGX) yield today?

A rentabilidade de Soligenix (SNGX) foi de -8.48% no último mês, -86.25% no último ano e -99.85% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Soligenix (SNGX) hoje, o investimento total seria de US$ 37.00, com base na cotação atual de US$ 0.37.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5.09
Em 5 anos: US$ 0.06
Em 10 anos: US$ 0.007400

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SNGX

Soligenix Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SNGX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SNGX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Soligenix

Soligenix Inc.

United States

39 years

1994

18

PROFIT X PRICE SNGX

Financial Results SNGX

SNGX cash flow

Asset, Revenue and Profit Growth - SNGX

SNGX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions